CohBar, Inc. (CWBR)

0.4900 0.0000 (0.00%) At close: 04:00PM EDT

CohBar, Inc.

1455 Adams Drive
Suite 2050
Menlo Park, CA 94025
United States
650 446 7888
https://www.cohbar.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 9

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Pinchas Cohen Dean, M.D., Ph.D.	Founder & Member of Scientific Advisory Board	65.25k	N/A	1957
Dr. Nir Yacov Barzilai M.D.	Founder & Member of Scientific Advisory Board	65.25k	N/A	1956
Dr. John M. Amatruda M.D., Ph.D.	Co-Founder	31.5k	N/A	1945
Ms. Jordyn Tarazi	Director of Investor Relations	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

Corporate Governance

CohBar, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.